Michael J. Katovich
Affiliations: | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Pharmacology, Molecular Biology, Pharmaceutical ChemistryGoogle:
"Michael Katovich"Mean distance: (not calculated yet)
Children
Sign in to add traineeAlok S. Pachori | grad student | 2001 | UF Gainesville |
Caren R. Beck | grad student | 2005 | UF Gainesville |
Justin L. Grobe | grad student | 2006 | UF Gainesville |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Li Calzi S, Cook T, Della Rocca DG, et al. (2019) Complementary Embryonic and Adult Cell Populations Enhance Myocardial Repair in Rat Myocardial Injury Model. Stem Cells International. 2019: 3945850 |
Sharma RK, Oliveira AC, Kim S, et al. (2018) Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension. Hypertension (Dallas, Tex. : 1979) |
Rathinasabapathy A, Horowitz A, Horton K, et al. (2018) The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. Frontiers in Physiology. 9: 180 |
Rathinasabapathy A, Bruce E, Espejo A, et al. (2016) Therapeutic potential of adipose stem cells derived conditioned medium against pulmonary hypertension and lung fibrosis. British Journal of Pharmacology |
Pei N, Wan R, Chen X, et al. (2015) Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts. Molecular Cancer Therapeutics |
Qi YF, Zhang J, Wang L, et al. (2015) Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. Journal of Molecular Medicine (Berlin, Germany) |
Cole-Jeffrey CT, Liu M, Katovich MJ, et al. (2015) ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy. Journal of Cardiovascular Pharmacology |
Bruce E, Shenoy V, Rathinasabapathy A, et al. (2015) Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. British Journal of Pharmacology. 172: 2219-31 |
Rathinasabapathy A, Horowitz A, Horton K, et al. (2015) C21, a nonpeptide angiotensin II type 2 receptor agonist attenuates lung fibrosis and associated cardiac dysfunction European Respiratory Journal. 46 |
Shenoy V, Yang T, Rathinasabapathy A, et al. (2015) Pp.21.33: The Microbial Metabolite, Butyrate Attenuates Pulmonary Hypertension Journal of Hypertension. 33 |